FRES Fresh2 Total Debt to Capital

Corporate emblem and logo of Fresh2 (FRES)

This daily price chart for Fresh2 Group Limited (FRES), which currently stands at 0.00, allows for an assessment of the business's resilience to logistics disruptions and patent disputes. Fresh2 Group Limited is implementing digital B2B tools to optimize supplies and improve operational transparency. Stable demand for diagnostics renders this sector independent of global crises, transforming the asset into a reliable defensive tool.

Debt to Equity Ratio: Fresh2 Group Ltd (FRES) for 02/21/2024 - 01/04/2025

Analytical breakdowns and data insights for company Fresh2 Group (FRES)

- price and consensus price forecast:
Price Chart Fresh2 Group Ltd|FRES - Consensus Target
- market capitalization data:
Market Capitalization Fresh2 Group|FRES - Total Enterprise Value
- book capitalization data:
Book Value per Share Fresh2 Group|FRES - Accounting Capitalization|Market Capitalization to Book Value Ratio fresh2.co|FRES - Company Total Assets
- debt and liquidity data:
Debt to Equity Fresh2 Group Limited|FRES - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Fresh2 Group Ltd|FRES - Company Aggregate Debts|Debt to Book Capitalization Ratio Fresh2 Group|FRES - Company Long-Term Debt|Company Current Liabilities Fresh2 Group
Summary company analysis:FRES, Fresh2 Group Limited
Signature product of Fresh2 Group

This ratio is calculated as the quotient of total debt obligations divided by total equity, measuring the business's degree of reliance on borrowed funds. For Fresh2 Group Limited, during the transformation of its B2B model, this debt-to-equity ratio serves as an indicator of management's financial stability in the face of market skepticism.

Analysis of competing companies

Debt to Equity A|Total Debt to Equity Ratio Quest Diagnostics Inc.|Illumina Corp - Total Debt to Capital|Debt to Capital Exact Sciences Inc. (EXAS)|RVTY - Total Debt to Capital|Debt to Equity Ratio bio-rad.com BIO|Anbio - Total Debt to Capital|SHC: Total Debt to Capital|Debt to Equity QuidelOrtho Corp|OPKO Health Corp. (OPK) - Debt to Equity Ratio|CDNA (CareDx Inc) - Total Debt to Capital|Total Debt to Capital MRVI|Debt to Equity Fulgent Genetics (FLGT)|Debt to Equity Standard BioTools Inc LAB|CTKB: Total Debt to Equity Ratio|OraSure Corp - Debt to Capital|Debt to Equity XGN (Exagen Diagnostics)|MDXH - Total Debt to Capital Coefficient|Lucid Diagnostics - Total Debt to Capital|PRE (Prenetics) - Total Debt to Capital Coefficient|IMDX: Debt to Equity|Total Debt to Capital Coefficient Trinity Biotech Corp|PRPH - Total Debt to Capital|Aggregate Debt to Equity AIMD (ainos.com)|Debt to Equity Co-Diagnostics|All Debt to Shareholders' Equity Ratio Heart Test Laboratories, Inc. HSCS|BMRA (Biomerica, Inc) - Total Debt to Capital|CDIO: Debt to Capital|Virax Biolabs Group - Debt to Equity|bluejaydx.com (BJDX) - Total Debt to Capital Coefficient|AWH - Total Debt to Capital|All Debt to Shareholders' Equity Ratio AXDX|Debt to Equity CNTG (CENTOGENE, N.V.)|ENZ (enzo.com) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio GENE (Genetic Technologies Limited)|Total Debt to Capital 23andme.com|PMD - Debt to Capital Ratio